---
schema_version: "secwatch.filing_event.v1"
accession: "0001493152-24-030671"
form_type: "8-K"
ticker: "INDP"
cik: "0001857044"
company_name: "Indaptus Therapeutics, Inc."
filed_at: "2024-08-08T23:59:59+00:00"
generated_at: "2026-05-31T11:17:33.336235+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.55
calibrated_materiality_score: 0.55
confidence: "high"
source: SEC EDGAR
---

# Indaptus raises ~$3M in registered direct offering and warrant private placement

## Summary
- Gross proceeds ~$3.0M from sale of 1,643,837 shares and warrants to purchase same number of shares.
- Combined purchase price $1.825 per share and warrant; warrant exercise price $1.70, 5-year term.
- CEO participating, purchasing 84,932 shares and warrants on same terms.
- Closing expected August 8, 2024; net proceeds for R&D and working capital.
- Paulson Investment Company acted as placement agent with 9% cash fee.

## SEC filing metadata
- accession: 0001493152-24-030671
- form_type: 8-K
- ticker: INDP
- cik: 0001857044
- company_name: Indaptus Therapeutics, Inc.
- filed_at: 2024-08-08T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.55
- calibrated_materiality_score: 0.55
- confidence: high
- sec_items: 1.01, 3.02, 8.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1857044/000149315224030671/0001493152-24-030671-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1857044/000149315224030671/form8-k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001493152-24-030671
- JSON: https://secwatch.observer/filing/0001493152-24-030671.json
- Plain text: https://secwatch.observer/filing/0001493152-24-030671.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.